DICE THERAPEUTICS INC's ticker is and the CUSIP is 23345J104. A total of 78 filers reported holding DICE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $485,275 | -22.3% | 10,445 | -52.1% | 0.01% | -23.5% |
| Q1 2023 | $624,828 | +102.7% | 21,809 | +120.8% | 0.02% | +88.9% |
| Q4 2022 | $308,194 | -13.7% | 9,878 | -43.9% | 0.01% | -30.8% |
| Q3 2022 | $357,000 | +2.3% | 17,605 | -21.7% | 0.01% | -18.8% |
| Q2 2022 | $349,000 | +13.3% | 22,497 | +39.9% | 0.02% | +14.3% |
| Q1 2022 | $308,000 | – | 16,084 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Northpond Ventures, LLC | 3,292,871 | $102,737,575 | 55.73% |
| Sands Capital Ventures, LLC | 2,748,970 | $85,768 | 23.49% |
| OUP Management Co., LLC | 268,346 | $8,372,395 | 13.67% |
| New Leaf Venture Partners, L.L.C. | 371,693 | $11,596,822 | 8.40% |
| RA Capital Management | 6,848,911 | $213,686,023 | 4.33% |
| VR Adviser, LLC | 819,000 | $25,552,800 | 4.30% |
| SVB FINANCIAL GROUP | 42,358 | $1,321,570 | 3.61% |
| Logos Global Management LP | 660,000 | $20,592,000 | 2.41% |
| Deep Track Capital, LP | 1,734,143 | $54,105,262 | 2.27% |
| Samsara BioCapital, LLC | 202,773 | $6,326,518 | 1.36% |